IP Verse

Bulle Dr patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest oppositions filed by Bulle Dr

Explore patent oppositions filed by Bulle Dr against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 22, 2025
EP3565419
Crystallisable D-Allulose SyrupsROQUETTE FRRESFeb 7, 2025
EP2395968
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 15, 2024
EP3626270
New UseNOVARTISJul 10, 2024
EP3532481
Method For Producing Allulose CrystalsTATE & LYLE INGREDIENTS AMERICASMar 14, 2024
EP3810201
Gip/Glp1 Agonist CompositionsELI LILLYMar 7, 2024
EP3294283
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISDec 8, 2023
EP3663375
Structural Adhesive CompositionsPPG INDUSTRIES OHIOOct 18, 2023
EP3067043
Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) InhibitorNOVARTISAug 28, 2023
EP3261455
Allulose SyrupsTATE & LYLE INGREDIENTS AMERICASOct 26, 2022

Top competitors of Bulle Dr

List of top competitors of Bulle Dr based on patent oppositions.